| Name | FTX-6746 |
|---|
| Description | FTX-6746 is an orally active PPARG inhibitor. FTX-6746 shows potent tumor inhibition in mouse xenograft models[1]. |
|---|---|
| Related Catalog | |
| Target |
PPARγ |
| In Vivo | FTX-6746 (3-60 mg/kg;口服;每天 2 次,共 21 天) 在小鼠的 UMUC9 或 HT1197 异种移植模型中有显着的肿瘤抑制作用[1]。 Animal Model: UMUC9 or HT1197 xenograft model in NCG or Balb/C nude mice[1] Dosage: 3 mg/kg, 10 mg/kg, 30 mg/kg, 60 mg/kg Administration: PO; twice daily for 21 days Result: Resulted >100% tumor growth inhibition at day 21 in HT1197 xenograft model. Resulted up to 80% target gene suppression in tumor tissue at day 2. |
| References |
| Molecular Formula | C16H7ClF2N2O |
|---|---|
| Molecular Weight | 316.69 |